Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Egan

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Investigative Ophthalmology & Visual Science|August 18, 2012
Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysisSimona Degli Esposti, Catherine Egan, Catey Bunce, et al.
Retina (Philadelphia, Pa.)|May 14, 2010
Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1Michel Michaelides, Samantha Fraser-Bell, Robin Hamilton, et al.
Clinical & Experimental Ophthalmology|February 23, 2008
A new phenotype of macular dystrophy associated with a mitochondrial A3243G mutationSobha Sivaprasad, Boom Ting Kung, Anthony G Robson, et al.
American Journal of Ophthalmology|September 18, 2016
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service SettingNamritha V Patrao, Sheelah Antao, Catherine Egan, et al.
American Journal of Ophthalmology|December 5, 2016
ReplyNamritha V Patrao, Sheelah Antao, Catherine Egan, et al.
The British Journal of Ophthalmology|March 7, 2020
Comparison of true-colour wide-field confocal scanner imaging with standard fundus photography for diabetic retinopathy screeningAbraham Olvera-Barrios, Tjebo Fc Heeren, Konstantinos Balaskas, et al.
Ophthalmology Science|February 23, 2026
Results from a Phase I Extension Study of Ciliary Neurotrophic Factor in Patients with Macular Telangiectasia Type 2Lawrence J Singerman, Jean-Pierre Hubschman, Martin Friedlander, et al.
The British Journal of Ophthalmology|May 8, 2020
Diagnostic accuracy of diabetic retinopathy grading by an artificial intelligence-enabled algorithm compared with a human standard for wide-field true-colour confocal scanning and standard digital retinal imagesAbraham Olvera-Barrios, Tjebo Fc Heeren, Konstantinos Balaskas, et al.
Ophthalmology. Retina|July 2, 2026
Masquerading disease of macular telangiectasia type 2 - MacTel Project Report No 11Laurenz Pauleikhoff, Peter Charbel Issa, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|August 1, 2024
OUTER RETINAL COLUMNAR ABNORMALITIES: A Novel Optical Coherence Tomography Sign of CRB1 Maculopathy?Gabriela Grimaldi, Moreno Menghini, Omar A Mahroo, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Investigative Ophthalmology & Visual Science|August 18, 2012
Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysisSimona Degli Esposti, Catherine Egan, Catey Bunce, et al.
Retina (Philadelphia, Pa.)|May 14, 2010
Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1Michel Michaelides, Samantha Fraser-Bell, Robin Hamilton, et al.
Clinical & Experimental Ophthalmology|February 23, 2008
A new phenotype of macular dystrophy associated with a mitochondrial A3243G mutationSobha Sivaprasad, Boom Ting Kung, Anthony G Robson, et al.
American Journal of Ophthalmology|September 18, 2016
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service SettingNamritha V Patrao, Sheelah Antao, Catherine Egan, et al.
American Journal of Ophthalmology|December 5, 2016
ReplyNamritha V Patrao, Sheelah Antao, Catherine Egan, et al.
The British Journal of Ophthalmology|March 7, 2020
Comparison of true-colour wide-field confocal scanner imaging with standard fundus photography for diabetic retinopathy screeningAbraham Olvera-Barrios, Tjebo Fc Heeren, Konstantinos Balaskas, et al.
Ophthalmology Science|February 23, 2026
Results from a Phase I Extension Study of Ciliary Neurotrophic Factor in Patients with Macular Telangiectasia Type 2Lawrence J Singerman, Jean-Pierre Hubschman, Martin Friedlander, et al.
The British Journal of Ophthalmology|May 8, 2020
Diagnostic accuracy of diabetic retinopathy grading by an artificial intelligence-enabled algorithm compared with a human standard for wide-field true-colour confocal scanning and standard digital retinal imagesAbraham Olvera-Barrios, Tjebo Fc Heeren, Konstantinos Balaskas, et al.
Ophthalmology. Retina|July 2, 2026
Masquerading disease of macular telangiectasia type 2 - MacTel Project Report No 11Laurenz Pauleikhoff, Peter Charbel Issa, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|August 1, 2024
OUTER RETINAL COLUMNAR ABNORMALITIES: A Novel Optical Coherence Tomography Sign of CRB1 Maculopathy?Gabriela Grimaldi, Moreno Menghini, Omar A Mahroo, et al.
Pageof 11